201. Benzalkonium chloride breaks down conjunctival immunological tolerance in a murine model
- Author
-
Florencia Sabbione, Pablo Elías Morande, Mirta Giordano, Jeremias Gaston Galletti, María Laura Gabelloni, Mónica Vermeulen, and Analía Silvina Trevani
- Subjects
Conjunctiva ,CIENCIAS MÉDICAS Y DE LA SALUD ,Immunology ,Inmunología ,BENZALKONIUM ,Biology ,T-Lymphocytes, Regulatory ,IMMUNOLOGY ,Cell Line ,Benzalkonium chloride ,Mice ,Immune system ,Antigen ,CONJUNTIVA ,Cell Movement ,medicine ,Immune Tolerance ,Immunology and Allergy ,Animals ,TOLERANCE ,Cells, Cultured ,NF-kappa B ,Interleukin ,Epithelial Cells ,purl.org/becyt/ford/3.1 [https] ,Dendritic Cells ,Epithelium ,In vitro ,Tolerance induction ,Medicina Básica ,medicine.anatomical_structure ,purl.org/becyt/ford/3 [https] ,Female ,biological phenomena, cell phenomena, and immunity ,Benzalkonium Compounds ,medicine.drug - Abstract
The impact of topical eye drops with benzalkonium chloride (BAK) as a preservative could involve more than the reported toxic effects on the ocular surface epithelium and ultimately affect the immune balance of the conjunctiva. We found that BAK not only impairs tolerance induction in a murine model, but leads to mild systemic immunization. Contrasting with antigen only-treated mice, there was no induction of interleukin 10-producing antigen-specific CD4 + cells in BAK-treated animals. Moreover, the tolerogenic capacity of migrating dendritic cells (DCs) was reduced, apparently involving differential conditioning by soluble epithelial factors. Accordingly, epithelial cells exposed in vitro to BAK were less suppressive and failed to induce tolerogenic DCs in culture. As this effect of BAK was dependent on epithelial nuclear factor κB pathway activation, our findings may provide new therapeutic targets. Thus, tolerance breakdown by BAK should be considered an important factor in the management of glaucoma and immune-mediated ocular surface disorders. © 2013 Society for Mucosal Immunology. Fil: Galletti, Jeremías Gastón. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina Fil: Gabelloni, María Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina Fil: Morande, Pablo Elías. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina Fil: Sabbione, Florencia. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina Fil: Vermeulen, Elba Monica. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina Fil: Trevani, Analía Silvina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina Fil: Giordano, Mirta Nilda. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina
- Published
- 2012